| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $46.4M | $65.0M | $45.1M |
| YoY Revenue Growth % | -28.6% | +44.3% | — |
| Gross Profit | -$5.8M | -$5.8M | — |
| Gross Margin % | -12.6% | -8.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$16.0M | -$16.6M | -$30.5M |
| Operating Margin % | -34.5% | -25.5% | -67.8% |
| Net Income (GAAP) | -$16.6M | -$11.8M | -$24.2M |
| EBITDA (Normalized) | -$10.9M | -$14.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$25.2M | -$5.4M | -$7.3M |
| Capital Expenditures (CapEx) | $6.4M | $2.5M | — |
| Free Cash Flow (FCF) | -$31.6M | -$7.8M | -$7.3M |
| FCF Margin % | -68.0% | -12.0% | -16.2% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $21.8M | $1.3M | — |
| Total Debt (Short + Long Term) | $39.6M | $26.4M | — |
| Total Stockholders' Equity | -$12.1M | -$10.3M | — |